Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Good Doctor Pharmaceutical Group is a leading Chinese pharmaceutical conglomerate that integrates research, development, manufacturing, and sales of Traditional Chinese Medicine (TCM) and modern healthcare products. The company is most famous for its flagship product, Kangfuxin Liquid, which utilizes a standardized extract from Periplaneta americana to promote tissue repair and treat gastrointestinal ulcers. With a history dating back to 1986, the group has established a comprehensive industrial chain including GAP-certified medicinal herb cultivation bases and state-of-the-art GMP manufacturing facilities. Its therapeutic focus spans gastroenterology, hepatology, pediatrics, and dermatology, supported by several dedicated research institutes. Good Doctor is recognized as a top-tier enterprise in the Chinese pharmaceutical industry, consistently ranking among the country's most influential TCM brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 好医生药业集团.